The prognostic significance of vascular channel involvement and deep stromal penetration in early cervical carcinoma
Tumor recurrence and survival in stage IB cancer of the cervix
Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary A Gynecologic Oncology Group Study
m-AMSA in epithelial carcinoma of the ovary A Southwest Oncology Group study
Radiation therapy for treatment of intraductal carcinoma of the breast
Serial tests of carcinoembryonic antigen in patients with breast cancer
Local-regional treatment of patients with simultaneous local-regional recurrence and distant metastases following mastectomy
Continuous vindesine infusion in advanced head and neck cancer
Bleomycin and cis-platinum with or without mitomycin C in 110 previously untreated patients with head and neck cancer
The effective use of combined modality therapy for the treatment of patients with Hodgkin's disease who relapsed following radiotherapy
Occurrence of acute nonlymphocy tic leukemia in a prospective randomized study of treatment for Hodgkin's disease
A phase II study of 6-diazo-5-oxo-L-norleucine (DON, NSC-7365) in advanced large bowel carcinoma
Lack of potentiation of vincristine-induced neurotoxicity by VP-16–213
Effect of spirogermanium on V79 Chinese hamster cells
Assessment of the quality of life in long-term survivors after definitive radiotherapy
Behavior of cancer patients
Cancer chemotherapy via ambulatory infusion pump
Phase I study of cyclopliosphamide (NSC 26271) by 72-hour continuous intravenous infusion
Cis-platinum plus high-dose methotrexate Toxicity and efficacy in ovarian carcinoma
Hypothesis
Radiation Biology
Gynecologic Oncology. Fundamental Principles and Clinical Practice
Predictive Drug Testing on Human Tumor Cells
Fourth NCI-EORTC Symposium on New Drugs in Cancer Therapy Brussels, Belgium, December 15–17, 1983
INFORMATION FOR AUTHORS